Skip to Content

TBG Diagnostics Ltd TDLAF

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

TBG Diagnostics Ltd is engaged in research, development, and manufacturing of molecular diagnostics kits, instruments, services, and products. The operating business segment is InVitro Diagnostics, engaged with the research of biological drugs and retail and wholesale of veterinary drugs with operations mainly in Taiwan and China. Its molecular typing laboratory provides a suite of HLA-typing service certified by American Society of Histocompatibility and Immunology.

Contact
101 Collins Street, Level 27
Melbourne, VIC, 3000, Australia
T +61 730887926
Sector Healthcare
Industry Diagnostics & Research
Most Recent Earnings
Fiscal Year End Dec 31, 2020
Stock Type
Employees 41